• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激光原位角膜磨镶术后干眼患者应用双氯非腙四钠和玻璃酸钠联合治疗。

Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.

机构信息

Minamiaoyama Eye Clinic, Tokyo, Japan.

Minamiaoyama Eye Clinic, Tokyo, Japan.

出版信息

Am J Ophthalmol. 2014 Mar;157(3):616-22.e1. doi: 10.1016/j.ajo.2013.11.017. Epub 2013 Nov 27.

DOI:10.1016/j.ajo.2013.11.017
PMID:24528935
Abstract

PURPOSE

To evaluate the possible advantages of combination therapy with diquafosol tetrasodium and sodium hyaluronate for dry eye after laser in situ keratomileusis (LASIK).

DESIGN

Prospective randomized comparative trial.

METHODS

A total of 206 eyes of 105 patients who underwent LASIK were enrolled in this study. Patients were randomly assigned to 1 of 4 treatment groups according to the postoperative treatment: artificial tears, sodium hyaluronate, diquafosol tetrasodium, and a combination of hyaluronate and diquafosol. Questionnaire responses reflecting subjective dry eye symptoms, uncorrected and corrected visual acuity, functional visual acuity, manifest refraction, tear break-up time, fluorescein corneal staining, Schirmer test, and corneal sensitivity were examined before and 1 week and 1 month after LASIK.

RESULTS

Distance uncorrected visual acuity was significantly better in the combination group than in the hyaluronate group 1 week and 1 month after LASIK. Near uncorrected visual acuity was significantly better in the combination group than in the artificial tear and diquafosol groups 1 week and 1 month after LASIK. Distance functional visual acuity improved significantly only in the combination group 1 month after LASIK. The Schirmer value in the combination group was significantly higher than that in the hyaluronate group at 1 month after LASIK. Subjective dry eye symptoms in the combination group improved significantly compared with those in the other groups 1 week after surgery.

CONCLUSIONS

Our results suggest that hyaluronate and diquafosol combination therapy is beneficial for early stabilization of visual performance and improvement of subjective dry eye symptoms in patients after LASIK.

摘要

目的

评估二氢沙奎那林四钠盐和透明质酸钠联合治疗 LASIK 术后干眼症的可能优势。

设计

前瞻性随机对照试验。

方法

共纳入 206 只眼 105 例接受 LASIK 手术的患者参与本研究。患者根据术后治疗随机分为 4 个治疗组:人工泪液、透明质酸钠、二氢沙奎那林四钠盐和透明质酸钠与二氢沙奎那林联合治疗。术前及 LASIK 术后 1 周和 1 个月检查反映主观干眼症状、未矫正和矫正视力、功能性视力、明视折射、泪膜破裂时间、荧光素角膜染色、泪液分泌试验和角膜敏感性的问卷调查结果。

结果

LASIK 术后 1 周和 1 个月,联合组的远距未矫正视力明显优于透明质酸钠组。LASIK 术后 1 周和 1 个月,联合组的近距未矫正视力明显优于人工泪液组和二氢沙奎那林组。仅在联合组,术后 1 个月的远距功能性视力显著改善。联合组的 Schirmer 值在 LASIK 术后 1 个月时明显高于透明质酸钠组。与其他组相比,联合组的术后 1 周的主观干眼症状明显改善。

结论

我们的结果表明,透明质酸钠和二氢沙奎那林联合治疗有利于 LASIK 术后患者早期稳定视力表现和改善主观干眼症状。

相似文献

1
Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.激光原位角膜磨镶术后干眼患者应用双氯非腙四钠和玻璃酸钠联合治疗。
Am J Ophthalmol. 2014 Mar;157(3):616-22.e1. doi: 10.1016/j.ajo.2013.11.017. Epub 2013 Nov 27.
2
Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.四水合二喹法索滴眼液对激光原位角膜磨镶术后持续性干眼的疗效
Cornea. 2014 Jul;33(7):659-62. doi: 10.1097/ICO.0000000000000136.
3
Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.不含防腐剂的透明质酸钠 0.1%滴眼剂治疗地夸磷索 3%滴眼剂治疗干眼综合征的增效作用。
Cornea. 2014 Sep;33(9):935-41. doi: 10.1097/ICO.0000000000000213.
4
Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.3% 地夸磷索眼用溶液对白内障术后干眼患者的临床疗效及安全性:一项随机对照试验
Am J Ophthalmol. 2016 Mar;163:122-131.e2. doi: 10.1016/j.ajo.2015.12.002. Epub 2015 Dec 11.
5
Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye.地夸磷索钠滴眼剂对短瞬目干眼患者视功能的影响。
J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):595-603. doi: 10.1089/jop.2012.0246. Epub 2013 Mar 28.
6
Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.双氯非腙四钠对玻璃酸钠单药治疗干眼症的附加效应的临床评价:一项前瞻性、随机、多中心研究。
Eye (Lond). 2012 Oct;26(10):1363-8. doi: 10.1038/eye.2012.166. Epub 2012 Aug 10.
7
Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.地夸磷索钠滴眼液 3 %:用于治疗干眼症的评价。
Drugs. 2015 May;75(8):911-22. doi: 10.1007/s40265-015-0409-7.
8
Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.使用干眼相关生活质量评分问卷评估地夸磷索滴眼液对干眼患者生活质量的影响:对阅读和使用视觉显示终端患者的有效性。
Cornea. 2017 Aug;36(8):908-914. doi: 10.1097/ICO.0000000000001241.
9
Diquafosol ophthalmic solution for dry eye treatment.地夸磷索钠滴眼液治疗干眼症。
Adv Ther. 2012 Jul;29(7):579-89. doi: 10.1007/s12325-012-0033-9. Epub 2012 Jul 27.
10
Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.用于治疗干眼症的地夸磷索钠滴眼液:泪液成分的临床评估和生化分析
Jpn J Ophthalmol. 2015 Nov;59(6):415-20. doi: 10.1007/s10384-015-0408-y. Epub 2015 Aug 27.

引用本文的文献

1
Impact of dry eye disease treatment on patient quality of life.干眼症治疗对患者生活质量的影响。
Front Med (Lausanne). 2024 Feb 28;11:1305579. doi: 10.3389/fmed.2024.1305579. eCollection 2024.
2
Combination Therapy With Diquafosol Sodium and Sodium Hyaluronate in Eyes With Dry Eye Disease After Small Incision Lenticule Extraction.经微切口透镜切除术治疗的干眼患者中,双氯苯双胍己烷钠盐和玻璃酸钠联合治疗的效果。
In Vivo. 2023 Nov-Dec;37(6):2829-2834. doi: 10.21873/invivo.13397.
3
Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens.
地夸磷索滴眼液短期应用对佩戴角膜塑形镜的干眼患儿有益。
Front Med (Lausanne). 2023 Jul 13;10:1130117. doi: 10.3389/fmed.2023.1130117. eCollection 2023.
4
Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted keratomileusis.3% 地夸磷索四钠滴眼液与透明质酸钠联合治疗:飞秒激光制瓣准分子原位角膜磨镶术后干眼症患者的有效治疗方法
Front Med (Lausanne). 2023 Apr 20;10:1160499. doi: 10.3389/fmed.2023.1160499. eCollection 2023.
5
Post-LASIK dry eye disease: A comprehensive review of management and current treatment options.准分子激光原位角膜磨镶术后干眼症:管理与当前治疗选择的综合综述
Front Med (Lausanne). 2023 Apr 11;10:1057685. doi: 10.3389/fmed.2023.1057685. eCollection 2023.
6
Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials.局部滴眼用二喹沃司他治疗干眼的安全性和有效性:随机对照试验的更新荟萃分析。
Indian J Ophthalmol. 2023 Apr;71(4):1304-1315. doi: 10.4103/IJO.IJO_268_23.
7
Refractive surgery and dry eye - An update.屈光手术与干眼:最新进展。
Indian J Ophthalmol. 2023 Apr;71(4):1105-1114. doi: 10.4103/IJO.IJO_3406_22.
8
Sodium hyaluronate combined with rhEGF contributes to alleviate clinical symptoms and Inflammation in patients with Xerophthalmia after cataract surgery.玻璃酸钠联合 rhEGF 有助于缓解白内障术后干眼症患者的临床症状和炎症。
BMC Ophthalmol. 2022 Feb 7;22(1):58. doi: 10.1186/s12886-022-02275-4.
9
Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.准分子激光原位角膜磨镶术后干眼的管理:一种新型多成分人工泪液与羧甲基纤维素的多中心随机对照研究
Clin Ophthalmol. 2018 May 7;12:839-848. doi: 10.2147/OPTH.S163744. eCollection 2018.
10
A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers.一项用于治疗办公室工作人员干眼综合征的两种粘蛋白促分泌剂的前瞻性、随机试验。
Sci Rep. 2017 Nov 9;7(1):15210. doi: 10.1038/s41598-017-13121-9.